SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (4969)7/23/1998 2:31:00 PM
From: Izzy  Read Replies (2) of 6136
 
"Food for thought" (my theory): What if the company is being split into two so that AGPH General can be bought out by a big pharma, who might not be interested in AGPH's cancer drug pipeline? Then Johnson et al can stay with AGPH #2 biotech co. Also, from my experience, AGPH IR people are far from being amateurs. What can they possibly say at this time to the general public? I think we'll find out more in a few weeks' time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext